These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 22450981)
21. Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial. Morillo CA; Waskin H; Sosa-Estani S; Del Carmen Bangher M; Cuneo C; Milesi R; Mallagray M; Apt W; Beloscar J; Gascon J; Molina I; Echeverria LE; Colombo H; Perez-Molina JA; Wyss F; Meeks B; Bonilla LR; Gao P; Wei B; McCarthy M; Yusuf S; J Am Coll Cardiol; 2017 Feb; 69(8):939-947. PubMed ID: 28231946 [TBL] [Abstract][Full Text] [Related]
22. Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. de Andrade AL; Zicker F; de Oliveira RM; Almeida Silva S; Luquetti A; Travassos LR; Almeida IC; de Andrade SS; de Andrade JG; Martelli CM Lancet; 1996 Nov; 348(9039):1407-13. PubMed ID: 8937280 [TBL] [Abstract][Full Text] [Related]
23. Benznidazole prevents endothelial damage in an experimental model of Chagas disease. Molina-Berríos A; Campos-Estrada C; Lapier M; Duaso J; Kemmerling U; Galanti N; Leiva M; Ferreira J; López-Muñoz R; Maya JD Acta Trop; 2013 Jul; 127(1):6-13. PubMed ID: 23529066 [TBL] [Abstract][Full Text] [Related]
24. Benznidazole, itraconazole, and their combination for the treatment of chronic experimental Chagas disease in dogs. Cunha ELA; Torchelsen FKVDS; Fonseca KDS; Sousa LRD; Vieira PMA; Carneiro CM; Pinto KMC; Torres RM; Lana M Exp Parasitol; 2022 Jul; 238():108266. PubMed ID: 35490799 [TBL] [Abstract][Full Text] [Related]
25. Tolerance of benznidazole in treatment of Chagas' disease in adults. Pinazo MJ; Muñoz J; Posada E; López-Chejade P; Gállego M; Ayala E; del Cacho E; Soy D; Gascon J Antimicrob Agents Chemother; 2010 Nov; 54(11):4896-9. PubMed ID: 20823286 [TBL] [Abstract][Full Text] [Related]
26. Efficacy of continuous versus intermittent administration of nanoformulated benznidazole during the chronic phase of Trypanosoma cruzi Nicaragua infection in mice. Rial MS; Arrúa EC; Natale MA; Bua J; Esteva MI; Prado NG; Laucella SA; Salomon CJ; Fichera LE J Antimicrob Chemother; 2020 Jul; 75(7):1906-1916. PubMed ID: 32274510 [TBL] [Abstract][Full Text] [Related]
27. Systematic Review and Meta-analysis of the Pharmacokinetics of Benznidazole in the Treatment of Chagas Disease. Wiens MO; Kanters S; Mills E; Peregrina Lucano AA; Gold S; Ayers D; Ferrero L; Krolewiecki A Antimicrob Agents Chemother; 2016 Dec; 60(12):7035-7042. PubMed ID: 27550362 [TBL] [Abstract][Full Text] [Related]
29. Elucidating the impact of low doses of nano-formulated benznidazole in acute experimental Chagas disease. Rial MS; Scalise ML; Arrúa EC; Esteva MI; Salomon CJ; Fichera LE PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006119. PubMed ID: 29267280 [TBL] [Abstract][Full Text] [Related]
30. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II). Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788 [TBL] [Abstract][Full Text] [Related]
31. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV. Zanusso Junior G; Massago M; Kian D; Toledo MJO Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891 [TBL] [Abstract][Full Text] [Related]
32. The role of benznidazole with cyanocobalamin and ascorbic acid in treating the chronic phase of Chagas disease. Ghobadifar MA; Kalani N; Gitiforouz M; Mosallanejad Z Rev Soc Bras Med Trop; 2014; 47(5):669. PubMed ID: 25467275 [No Abstract] [Full Text] [Related]
33. Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease. Paniz-Mondolfi AE; Pérez-Alvarez AM; Lanza G; Márquez E; Concepción JL Chemotherapy; 2009; 55(4):228-33. PubMed ID: 19451712 [TBL] [Abstract][Full Text] [Related]
34. Benznidazole/Poloxamer 407 Solid Dispersion as a New Strategy to Improve the Treatment of Experimental Trypanosoma cruzi Infection. Davies C; Simonazzi A; Micheloud JF; Ragone PG; Cid AG; Negrette OS; Bermúdez JM; Parada LA J Parasitol; 2020 Jun; 106(3):323-333. PubMed ID: 32369594 [TBL] [Abstract][Full Text] [Related]
35. Chagas' disease: lymphoma growth in rabbits treated with Benznidazole. Teixeira AR; Córdoba JC; Souto Maior I; Solórzano E Am J Trop Med Hyg; 1990 Aug; 43(2):146-58. PubMed ID: 2117856 [TBL] [Abstract][Full Text] [Related]
36. The effect of benznidazole dose among the efficacy outcome in the murine animal model. A quantitative integration of the literature. Molina I; Perin L; Aviles AS; de Abreu Vieira PM; da Silva Fonseca K; Cunha LM; Carneiro CM Acta Trop; 2020 Jan; 201():105218. PubMed ID: 31610148 [TBL] [Abstract][Full Text] [Related]
37. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Filardi LS; Brener Z Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683 [TBL] [Abstract][Full Text] [Related]